A carregar...

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy

This study was undertaken to evaluate the connexin hemichannel blocker tonabersat for the inhibition of inflammasome activation and use as a potential treatment for diabetic retinopathy. Human retinal pigment epithelial cells (ARPE-19) were stimulated with hyperglycemia and the inflammatory cytokine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Lyon, Heather, Shome, Avik, Rupenthal, Ilva D., Green, Colin R., Mugisho, Odunayo O.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794685/
https://ncbi.nlm.nih.gov/pubmed/33396676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22010298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!